Transgenomic, Inc. - TBIO- Profile

Transgenomic, Inc.. The Group's principal activity is to provide innovative products and services for the synthesis, purification and analysis of nucleic acids. The Group operates in two segments: BioSystems and Nucleic Acids. The BioSystems segment sells automated instrument systems, associated consumable products and chemical building blocks for nucleic acid synthesis. The segment's main products are the WAVE system, related bio-consumables and research services. The Nucleic Acids segment sells products and services based upon Group's core competencies, nucleic acid chemistries, separations chemistries and enzymology. This segment's main products are nucleic acid building blocks or phosphoramidites, oligonucleotides, fluorescent markers, dyes and associated reagents and novel chemistry and process development services. The Group operates in the United States, Europe, Pacific Rim and other Countries. BioSystems accounted for 90% of 2005 revenues and Discovery Services, 10%